1. Home
  2. WEAV vs NNNN Comparison

WEAV vs NNNN Comparison

Compare WEAV & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • NNNN
  • Stock Information
  • Founded
  • WEAV 2011
  • NNNN 2021
  • Country
  • WEAV United States
  • NNNN Germany
  • Employees
  • WEAV N/A
  • NNNN N/A
  • Industry
  • WEAV EDP Services
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • WEAV Technology
  • NNNN Health Care
  • Exchange
  • WEAV Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • WEAV 837.7M
  • NNNN 267.7M
  • IPO Year
  • WEAV 2021
  • NNNN 2025
  • Fundamental
  • Price
  • WEAV $10.46
  • NNNN $6.63
  • Analyst Decision
  • WEAV Strong Buy
  • NNNN
  • Analyst Count
  • WEAV 5
  • NNNN 0
  • Target Price
  • WEAV $16.10
  • NNNN N/A
  • AVG Volume (30 Days)
  • WEAV 665.2K
  • NNNN 32.8K
  • Earning Date
  • WEAV 05-05-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • WEAV N/A
  • NNNN N/A
  • EPS Growth
  • WEAV N/A
  • NNNN N/A
  • EPS
  • WEAV N/A
  • NNNN 0.06
  • Revenue
  • WEAV $212,950,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • WEAV $17.08
  • NNNN N/A
  • Revenue Next Year
  • WEAV $15.39
  • NNNN N/A
  • P/E Ratio
  • WEAV N/A
  • NNNN $116.38
  • Revenue Growth
  • WEAV 19.58
  • NNNN 21.95
  • 52 Week Low
  • WEAV $8.10
  • NNNN $5.18
  • 52 Week High
  • WEAV $17.63
  • NNNN $7.82
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 50.92
  • NNNN N/A
  • Support Level
  • WEAV $9.06
  • NNNN N/A
  • Resistance Level
  • WEAV $10.99
  • NNNN N/A
  • Average True Range (ATR)
  • WEAV 0.50
  • NNNN 0.00
  • MACD
  • WEAV 0.13
  • NNNN 0.00
  • Stochastic Oscillator
  • WEAV 76.13
  • NNNN 0.00

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: